|
US6150328A
(en)
|
1986-07-01 |
2000-11-21 |
Genetics Institute, Inc. |
BMP products
|
|
US5457038A
(en)
*
|
1988-11-10 |
1995-10-10 |
Genetics Institute, Inc. |
Natural killer stimulatory factor
|
|
US5811523A
(en)
*
|
1988-11-10 |
1998-09-22 |
Trinchieri; Giorgio |
Antibodies to natural killer stimulatory factor
|
|
DE69034249T2
(de)
*
|
1989-12-22 |
2008-05-29 |
F. Hoffmann-La Roche Ag |
Monoklonale Antikörper spezifisch für den zytotoxischen Lymphozyten-Reifefaktor
|
|
US5780597A
(en)
*
|
1989-12-22 |
1998-07-14 |
Hoffmann-La Roche Inc. |
Monoclonal antibodies to cytotoxic lymphocyte maturation factor
|
|
WO1993009229A1
(en)
|
1991-11-04 |
1993-05-13 |
Genetics Institute, Inc. |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
|
US20080139474A1
(en)
*
|
1991-11-04 |
2008-06-12 |
David Israel |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
|
US6399379B1
(en)
|
1992-09-29 |
2002-06-04 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of interleukin 12 p35 subunit expression
|
|
CA2125763C
(en)
*
|
1993-07-02 |
2007-08-28 |
Maurice Kent Gately |
P40 homodimer of interleukin-12
|
|
US6291206B1
(en)
|
1993-09-17 |
2001-09-18 |
Genetics Institute, Inc. |
BMP receptor proteins
|
|
AU689184B2
(en)
*
|
1993-12-07 |
1998-03-26 |
Genetics Institute, Llc |
BMP-12, BMP-13 and tendon-inducing compositions thereof
|
|
ZA95960B
(en)
*
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
|
US6706264B1
(en)
|
1994-03-14 |
2004-03-16 |
Genetics Institute, Llc |
Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y
|
|
US5571515A
(en)
*
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
|
US5635182A
(en)
*
|
1994-06-16 |
1997-06-03 |
Genetics Institute, Inc. |
Method of detecting ligand interactions
|
|
DE69519454T2
(de)
|
1994-07-14 |
2001-05-03 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama |
Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
|
|
US7135458B1
(en)
|
1995-11-15 |
2006-11-14 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
|
|
JP2724987B2
(ja)
|
1994-11-15 |
1998-03-09 |
株式会社林原生物化学研究所 |
インターフェロン−γの産生を誘導するポリペプチド
|
|
JP4004088B2
(ja)
|
1995-09-26 |
2007-11-07 |
株式会社林原生物化学研究所 |
免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
|
|
TW464656B
(en)
*
|
1994-11-15 |
2001-11-21 |
Hayashibara Biochem Lab |
Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
|
|
US5674483A
(en)
*
|
1995-01-31 |
1997-10-07 |
National Jewish Medical And Research Center |
Treatment for diseases involving inflammation
|
|
JP2000510813A
(ja)
*
|
1995-02-06 |
2000-08-22 |
ジェネテイックス・インスティテュート・インコーポレイテッド |
Ｉｌ−１２用処方
|
|
US5891680A
(en)
*
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
|
US6372208B1
(en)
|
1999-09-28 |
2002-04-16 |
The Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
|
US6251957B1
(en)
|
1995-02-24 |
2001-06-26 |
Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant virus
|
|
US5872154A
(en)
*
|
1995-02-24 |
1999-02-16 |
The Trustees Of The University Of Pennsylvania |
Method of reducing an immune response to a recombinant adenovirus
|
|
US5853714A
(en)
*
|
1995-03-27 |
1998-12-29 |
Genetics Institute, Inc. |
Method for purification of IL-12
|
|
US6509313B1
(en)
|
1996-02-28 |
2003-01-21 |
Cornell Research Foundation, Inc. |
Stimulation of immune response with low doses of cytokines
|
|
GB9609932D0
(en)
*
|
1996-05-13 |
1996-07-17 |
Hoffmann La Roche |
Use of IL-12 and IFN alpha for the treatment of infectious diseases
|
|
JP2001503258A
(ja)
*
|
1996-10-18 |
2001-03-13 |
バレンティス・インコーポレーテッド |
遺伝子発現および搬送系および用途
|
|
EP0956301A2
(en)
*
|
1996-10-18 |
1999-11-17 |
Valentis Inc. |
Il-12 gene expression and delivery systems and uses
|
|
AU729579B2
(en)
*
|
1996-10-23 |
2001-02-01 |
Trustees Of The University Of Pennsylvania, The |
Immunotherapy and improved vaccines
|
|
US5994104A
(en)
*
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
|
WO1998041229A1
(en)
*
|
1997-03-19 |
1998-09-24 |
F. Hoffmann-La Roche Ag |
USE OF IL-12p40 AS IMMUNOSTIMULANT
|
|
JP2001521906A
(ja)
*
|
1997-11-03 |
2001-11-13 |
ザ・ウイスター・インステイテユート・オブ・アナトミー・アンド・バイオロジー |
血管新生を阻害し、癌を処置するための方法及び組成物
|
|
ES2590912T3
(es)
|
1997-12-08 |
2016-11-24 |
Merck Patent Gmbh |
Proteínas de fusión heterodiméricas útiles para inmunoterapia dirigida y estimulación general del sistema inmunitario
|
|
US7026456B1
(en)
*
|
1998-01-23 |
2006-04-11 |
Hoffman-La Roche, Inc. |
Antibodies against human IL-12
|
|
EP1049484B1
(en)
*
|
1998-01-23 |
2004-03-31 |
Genetics Institute, LLC |
Use of il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
|
|
US20030105294A1
(en)
*
|
1998-02-25 |
2003-06-05 |
Stephen Gillies |
Enhancing the circulating half life of antibody-based fusion proteins
|
|
US7247442B1
(en)
|
1998-05-12 |
2007-07-24 |
Human Genome Sciences, Inc. |
Antibodies to HHPEN62 polypeptide
|
|
US6375944B1
(en)
|
1998-09-25 |
2002-04-23 |
The Wistar Institute Of Anatomy And Biology |
Methods and compositions for enhancing the immunostimulatory effect of interleukin-12
|
|
US6448081B1
(en)
*
|
2001-05-07 |
2002-09-10 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of interleukin 12 p40 subunit expression
|
|
US6727224B1
(en)
*
|
1999-02-01 |
2004-04-27 |
Genetics Institute, Llc. |
Methods and compositions for healing and repair of articular cartilage
|
|
MXPA01008626A
(es)
*
|
1999-02-26 |
2002-04-24 |
Univ Johns Hopkins |
Inhibidor novedoso de muerte programada de celula.
|
|
US6800460B1
(en)
*
|
1999-03-11 |
2004-10-05 |
Schering Corporation |
Mammalian cytokine complexes
|
|
EP1161447A1
(en)
*
|
1999-03-12 |
2001-12-12 |
Human Genome Sciences, Inc. |
50 human secreted proteins
|
|
WO2000055201A1
(en)
*
|
1999-03-12 |
2000-09-21 |
Human Genome Sciences, Inc. |
49 human secreted proteins
|
|
JP2002542766A
(ja)
*
|
1999-03-12 |
2002-12-17 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
５０個のヒト分泌タンパク質
|
|
AU3767000A
(en)
*
|
1999-03-26 |
2000-10-16 |
Human Genome Sciences, Inc. |
50 human secreted proteins
|
|
AU6745700A
(en)
*
|
1999-03-26 |
2000-11-02 |
Human Genome Sciences, Inc. |
49 human secreted proteins
|
|
AU4066800A
(en)
*
|
1999-04-01 |
2000-10-23 |
Genetics Institute Inc. |
Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same
|
|
CA2370523A1
(en)
*
|
1999-04-09 |
2000-10-19 |
Craig A. Rosen |
49 human secreted proteins
|
|
WO2001007476A1
(en)
*
|
1999-07-21 |
2001-02-01 |
Human Genome Sciences, Inc. |
26 human prostate and prostate cancer associated proteins
|
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
US7067110B1
(en)
|
1999-07-21 |
2006-06-27 |
Emd Lexigen Research Center Corp. |
Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
|
MXPA02001417A
(es)
|
1999-08-09 |
2002-08-12 |
Lexigen Pharm Corp |
Complejos multiples de citosina-anticuerpo.
|
|
JP2003507036A
(ja)
*
|
1999-08-16 |
2003-02-25 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
レチノイドレセプター相互作用ポリヌクレオチド、ポリペプチド、および抗体
|
|
AU7084500A
(en)
*
|
1999-09-03 |
2001-04-10 |
Human Genome Sciences, Inc. |
Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies
|
|
CA2384672A1
(en)
*
|
1999-09-09 |
2001-03-15 |
Human Genome Sciences, Inc. |
Steroid hormone receptor polynucleotides, polypeptides, and antibodies
|
|
JP2003511012A
(ja)
*
|
1999-09-24 |
2003-03-25 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
３２個のヒト分泌タンパク質
|
|
DK1223990T3
(da)
|
1999-10-15 |
2004-11-29 |
Inst Genetics Llc |
Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
|
|
CA2391080A1
(en)
|
1999-11-12 |
2001-05-25 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Erythropoietin forms with improved properties
|
|
US7115712B1
(en)
*
|
1999-12-02 |
2006-10-03 |
Maxygen, Inc. |
Cytokine polypeptides
|
|
EP1248801A4
(en)
*
|
2000-01-18 |
2003-08-27 |
Human Genome Sciences Inc |
HUMANE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES
|
|
WO2001055301A2
(en)
*
|
2000-01-31 |
2001-08-02 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
|
HUP0204475A2
(en)
*
|
2000-02-11 |
2003-04-28 |
Merck Patent Gmbh |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
AU2001238585A1
(en)
*
|
2000-02-24 |
2001-09-03 |
Human Genome Sciences, Inc. |
Human polynucleotides, polypeptides, and antibodies
|
|
EP1268541A1
(en)
*
|
2000-03-17 |
2003-01-02 |
Human Genome Sciences, Inc. |
7 human ovarian and ovarian cancer associated proteins
|
|
EP1278826A1
(en)
*
|
2000-03-31 |
2003-01-29 |
Genetics Institute, LLC |
Novel proteins
|
|
WO2001074896A1
(en)
*
|
2000-04-03 |
2001-10-11 |
Human Genome Sciences, Inc. |
Human polynucleotides, polypeptides, and antibodies
|
|
AU2001253362A1
(en)
*
|
2000-04-13 |
2001-10-30 |
Smith Kline Beecham Corporation |
Novel compounds
|
|
NZ523122A
(en)
*
|
2000-06-22 |
2004-06-25 |
Smithkline Beecham Corp |
Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
|
|
KR20030064275A
(ko)
*
|
2000-06-29 |
2003-07-31 |
메르크 파텐트 게엠베하 |
면역싸이토카인 흡수 증강제와의 조합 치료에 의한항체-싸이토카인 융합 단백질 매개 면역 반응 증강
|
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
|
CA2420902A1
(en)
*
|
2000-08-28 |
2002-03-07 |
Craig A. Rosen |
18 human secreted proteins
|
|
US20030082233A1
(en)
*
|
2000-12-01 |
2003-05-01 |
Lyons Karen M. |
Method and composition for modulating bone growth
|
|
RU2003129528A
(ru)
|
2001-03-07 |
2005-04-10 |
Мерк Патент ГмбХ (DE) |
Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела
|
|
WO2002079415A2
(en)
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
|
EP1383785B1
(en)
|
2001-05-03 |
2011-03-16 |
Merck Patent GmbH |
Recombinant tumor specific antibody and use thereof
|
|
US7226587B2
(en)
*
|
2001-06-01 |
2007-06-05 |
Wyeth |
Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
|
|
TWI267378B
(en)
*
|
2001-06-08 |
2006-12-01 |
Wyeth Corp |
Calcium phosphate delivery vehicles for osteoinductive proteins
|
|
DK1454138T3
(da)
|
2001-12-04 |
2012-02-13 |
Merck Patent Gmbh |
Immunocytokiner med moduleret selektivitet
|
|
WO2004055056A1
(en)
*
|
2002-12-17 |
2004-07-01 |
Merck Patent Gmbh |
Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2
|
|
US7939058B2
(en)
|
2003-07-03 |
2011-05-10 |
University Of Southern California |
Uses of IL-12 in hematopoiesis
|
|
JP5392981B2
(ja)
*
|
2003-09-12 |
2014-01-22 |
ワイス・エルエルシー |
骨形成蛋白の送達のための注入可能なリン酸カルシウム固体ロッドおよびペースト
|
|
EP1702069A2
(en)
*
|
2004-01-05 |
2006-09-20 |
EMD Lexigen Research Center Corp. |
Interleukin-12 targeted to oncofoetal fibronectin
|
|
US20040260068A1
(en)
*
|
2004-02-26 |
2004-12-23 |
Naoya Tsurushita |
Humanized chicken antibodies
|
|
TW200613554A
(en)
|
2004-06-17 |
2006-05-01 |
Wyeth Corp |
Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV
|
|
MY157915A
(en)
|
2004-12-21 |
2016-08-15 |
Centocor Inc |
Anti-il-12 antibodies, epitopes, compositions, methods and uses.
|
|
WO2006081379A1
(en)
*
|
2005-01-26 |
2006-08-03 |
Wyeth |
Use of sfrps as markers of bmp activity
|
|
EP1863518A2
(en)
*
|
2005-03-30 |
2007-12-12 |
Wyeth |
Methods for stimulating hair growth by administering bmps
|
|
PL1966238T3
(pl)
|
2005-12-30 |
2012-09-28 |
Merck Patent Gmbh |
Warianty interleukiny-12p40 o polepszonej stabilności
|
|
WO2008070647A1
(en)
*
|
2006-12-07 |
2008-06-12 |
Wyeth |
Methods and compositions for assessing il-12 or the neutralization of il-12 in a sample
|
|
EP2248903A1
(en)
|
2009-04-29 |
2010-11-10 |
Universitat Autònoma De Barcelona |
Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
|
|
JO3244B1
(ar)
|
2009-10-26 |
2018-03-08 |
Amgen Inc |
بروتينات ربط مستضادات il – 23 البشرية
|
|
US9878012B2
(en)
|
2010-05-18 |
2018-01-30 |
Neumedicines, Inc. |
IL-12 formulations for enhancing hematopoiesis
|
|
WO2012174056A1
(en)
|
2011-06-13 |
2012-12-20 |
Neumedicines, Inc. |
Mitigation of cutaneous injury with il-12
|
|
CA2843014C
(en)
|
2011-07-27 |
2020-01-21 |
Neumedicines, Inc. |
Use of il-12 to generate endogenous erythropoietin
|
|
JP2015505326A
(ja)
|
2012-01-18 |
2015-02-19 |
ニューメディシンズ，インコーポレーテッド |
放射線防護及び放射線誘発性毒性緩和のためのｉｌ−１２
|
|
US20140350087A9
(en)
|
2012-03-22 |
2014-11-27 |
Halozyme, Inc. |
Oncovector Nucleic Acid Molecules and Methods of Use
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
WO2017062953A1
(en)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
CN109071653A
(zh)
|
2016-03-29 |
2018-12-21 |
詹森生物科技公司 |
用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣
|
|
TW201922780A
(zh)
*
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗ｉｌ１２／ｉｌ２３抗體治療狼瘡之安全且有效之方法
|
|
EP3793521A4
(en)
|
2018-05-18 |
2022-02-23 |
Janssen Biotech, Inc. |
SAFE AND EFFECTIVE METHOD OF TREATING LUPUS WITH AN ANTI-IL12/IL23 ANTIBODY
|
|
IL326284A
(en)
|
2018-09-24 |
2026-04-01 |
Janssen Biotech Inc |
A safe and effective method for treating ulcerative colitis with an anti-IL12/IL23 antibody
|
|
JP7805788B2
(ja)
|
2019-05-23 |
2026-01-26 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
|
IL298389A
(en)
|
2020-05-21 |
2023-01-01 |
Janssen Biotech Inc |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
|
|
WO2023070038A2
(en)
*
|
2021-10-20 |
2023-04-27 |
Synthekine, Inc. |
Human il-12p40 variants and uses thereof
|
|
CA3234552A1
(en)
|
2021-10-20 |
2023-04-27 |
Synthekine, Inc. |
Heterodimeric fc cytokines and uses thereof
|